[ad_1]
Radnor, Pennsylvania, December 11, 2021 /PRNewswire/ – Law Firm Kessler Topaz Meltzer & Check, LLP Notify investors that Ginkgo Bioworks Holdings, Inc. (“Ginkgo”) (NYSE stock code:DNA) f/k/a Soaring Eagle Acquisition Corp. (NASDAQ:random number). The lawsuit accused Ginkgo of violating federal securities laws, including omissions and fraudulent misrepresentations related to the company’s business, operations, and prospects. Due to Ginkgo’s major misleading statements to the public, Ginkgo investors suffered heavy losses.
Can’t watch this video?Please click here
click here Submit your ginkgo loss
Deadline for lead plaintiff: January 18, 2022
class time: May 11, 2021 pass through October 5, 2021
Contact a lawyer to discuss your rights:
James Marlow, Esq. (484) 270-1453 or free (844) 887-9500 or email to info@ktmc.com
ginkgo Suspected misconduct
Ginkgo, headquartered in Boston, Is a biotechnology company that develops cell programming platforms for the biological production of products, such as new therapies, food ingredients, and chemicals currently extracted from petroleum.
exist October 6, 2021, Analyst Scorpion Capital An investigation report was published, and the conclusion was that “Ginkgo is a house of cards—in our opinion, this is one of the most shameless frauds in the past 20 years.” The report pointed out that Ginkgo’s business model is a related party model. 100% of the deferred income is basically…
The full story can be found on Benzinga.com
[ad_2]
Source link
